Summary
The broader impact/commercial potential of this Small Business Innovation Research (SBIR) Phase I project is a novel implantable lens for shifting the phase of visible-light phase to mitigate vision loss due to age related macular degeneration and damaged retinal regions. Age-related macular degeneration is a chronic and progressive eye disease affecting more than 20 million people in the US and 200 million people worldwide and often results in irreversible blindness. No permanent solution currently exists for treating age-related macular degeneration and mitigating vision loss until surgical
